Eligible medicare beneficiaries at participating healthcare providers will soon be able to purchase $500 worth of hemp-derived products annually for medical purposes.

Under a new Centers for Medicare and Medicaid Services pilot program that begins on Wednesday, participating healthcare providers can offer their eligible patients hemp-derived CBD and THC products for symptom control with no out-of-pocket cost to the patient.

Recommended Stories

Todd Blanche orders federal reclassification of medical marijuana as less dangerous

Hemp farmers prepare for planting season ahead of impending ban: ‘We are 100% taking a gamble’

Nancy Mace files legislation to strike hemp ban tucked into funding bill